DNA methylation patterns of peroxisome proliferator-activated receptor gamma gene associated with liver fibrosis and inflammation in chronic hepatitis B

Journal of Viral Hepatitis

Volumn 20, Issue 6, 2013, Pages 430-437

  Zhao, Q ^a,b   Fan, Y C ^a,b   Zhao, J ^a   Gao, S ^a   Zhao, Z H ^a   Wang, K ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

chronic hepatitis B; inflammation; liver fibrosis; methylation; peroxisome proliferator activated receptor gamma

Indexed keywords

DNA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ARTICLE; CELL ISOLATION; CHRONIC HEPATITIS B; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENETIC TRANSCRIPTION; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ALANINE TRANSAMINASE; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PPAR GAMMA; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84877578496     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12048     Document Type: Article

References (25)

1. Lok AS,. Chronic hepatitis B. N Engl J Med 2002; 346 (22): 1682-1683.
2. Connolly MK, Bedrosian AS, Mallen-St Clair J, et al,. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest 2009; 119 (11): 3213-3225.
3. Ramachandran P, Iredale JP,. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol 2012; 56 (6): 1417-1419.
4. Martinez-Gras I, Perez-Nievas BG, Garcia-Bueno B, et al,. Schizophr Res 2011; 128 (1-3): 15-22.
5. Xiao J, Leung JCK, Chan LYY, Tang SCW, Lai KN,. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy. Clin Immunol 2009; 132 (2): 266-276.
6. Yang J, Zhou Y, Guan Y,. PPARgamma as a therapeutic target in diabetic nephropathy and other renal diseases. Curr Opin Nephrol Hypertens 2012; 21 (1): 97-105.
7. Garcia-Bueno B, Caso JR, Perez-Nievas BG, Lorenzo P, Leza JC,. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 2007; 32 (6): 1251-1260.
8. Kim KH, Shin HJ, Kim K, et al,. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 2007; 132 (5): 1955-1967.
9. Lee TF, Lin YL, Huang YT,. Protective effects of kaerophyllin against liver fibrogenesis in rats. Eur J Clin Invest 2012; 42 (6): 607-616.
10. Yang L, Stimpson SA, Chen L, Wallace Harrington W, Rockey DC,. Effectiveness of the PPARgamma agonist, GW570, in liver fibrosis. Inflamm Res 2010; 59 (12): 1061-1071.
11. Yoon S, Jung J, Kim T, et al,. Adiponectin, a downstream target gene of peroxisome proliferator-activated receptor gamma, controls hepatitis B virus replication. Virology 2011; 409 (2): 290-298.
12. Yu J, Ni M, Xu J, et al,. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002; 2: 29.
13. Sugii S, Evans RM,. Epigenetic codes of PPARgamma in metabolic disease. FEBS Lett 2011; 585 (13): 2121-2128.
14. Li T, Meng QH, Zou ZQ, et al,. Correlation between promoter methylation of glutathione-S-transferase P1 and oxidative stress in acute-on-chronic hepatitis B liver failure. J Viral Hepatitis 2011; 18 (7): E226-E231.
15. Jeronimo C, Usadel H, Henrique R, et al,. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 2002; 60 (6): 1131-1135.
16. Szymczak A, Simon K, Inglot M, Gladysz A,. Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures. Hepat Mon 2012; 12 (1): 32-37.
17. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24 (2): 289-293.
18. Kuboki S, Shin T, Huber N, et al,. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. Hepatology 2008; 47 (1): 215-224.
19. Planaguma A, Claria J, Miquel R, et al,. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J 2005; 19 (9): 1120-1122.
20. Lima-Cabello E, Garcia-Mediavilla MV, Miquilena-Colina ME, et al,. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin Sci (Lond) 2011; 120 (6): 239-250.
21. Niu YH, Yi RT, Liu HL, Chen TY, Zhang SL, Zhao YR,. Expression of COX-2 and PPARg in the livers of patients with acute on chronic HBV-related liver failure and their relationship with clinic parameters. Zhonghua Gan Zang Bing Za Zhi 2011; 19 (7): 511-516.
22. Nishida N, Kudo M, Nagasaka T, Ikai I, Goel A,. Characteristic pattern of DNA methylation alterations predict emergence of human hepatocellular carcinoma. Hepatology 2012; 56(3): 994-1003.
23. Liu L, Li Y, Tollefsbol TO,. Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol 2008; 10 (1-2): 25-36.
24. Jiang C, Ting AT, Seed B,. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391 (6662): 82-86.
25. Duffield JS, Forbes SJ, Constandinou CM, et al,. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115 (1): 56-65.